Literature DB >> 11072216

Cervical cancer screening in Sweden.

J Dillner1.   

Abstract

Organised cervical cancer screening was implemented in Sweden in the mid-1960s. A marked decline in cervical cancer incidence could be attributed to the time-point of start of screening. Squamous cell carcinoma has declined by 60%, whereas adenocarcinoma has increased. About 950000 papanicolaou (Pap) smears are taken annually. Only 31% of the smears taken in the organised screening programme. As of 1998, the screening guidelines are 3-yearly tests between 23 and 50 years of age and 5-yearly tests between 50 and 60 years of age. The article reviews the screening practise in Sweden, the current efforts to improve the quality of the screening programme, as well as the ongoing randomised evaluations of organised primary screening for cervical human papilloma virus (HPV) infection.

Entities:  

Mesh:

Year:  2000        PMID: 11072216     DOI: 10.1016/s0959-8049(00)00320-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  9 in total

1.  Cells and the (imaginary) patient: the multistable practitioner-technology-cell interface in the cytology laboratory.

Authors:  Anette Forss
Journal:  Med Health Care Philos       Date:  2012-08

2.  Immigrant women's experiences and views on the prevention of cervical cancer: a qualitative study.

Authors:  Maria Grandahl; Tanja Tydén; Maria Gottvall; Ragnar Westerling; Marie Oscarsson
Journal:  Health Expect       Date:  2012-12-16       Impact factor: 3.377

3.  Community collaboration to increase foreign-born women's participation in a cervical cancer screening program in Sweden: a quality improvement project.

Authors:  Erik Olsson; Malena Lau; Svante Lifvergren; Alexander Chakhunashvili
Journal:  Int J Equity Health       Date:  2014-08-09

4.  Cervical cancer in the screening era: who fell victim in spite of successful screening programs?

Authors:  B Folke Pettersson; Kristina Hellman; Roxane Vaziri; Sonia Andersson; Ann-Cathrin Hellström
Journal:  J Gynecol Oncol       Date:  2011-06-30       Impact factor: 4.401

5.  Modelling the impact of population-based cytologic screening on cervical cancer incidence and mortality in Hong Kong: an age--period--cohort approach.

Authors:  P P S Woo; T Q Thach; S T B Choy; S M McGhee; G M Leung
Journal:  Br J Cancer       Date:  2005-10-31       Impact factor: 7.640

6.  Human papillomavirus testing in cervical cancer screening.

Authors:  S Franceschi; C Mahé
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

7.  Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.

Authors:  Jiangrong Wang; Bengt Andrae; Karin Sundström; Alexander Ploner; Peter Ström; K Miriam Elfström; Joakim Dillner; Pär Sparén
Journal:  PLoS Med       Date:  2017-10-24       Impact factor: 11.069

8.  Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine.

Authors:  Karl-Ulrich Petry; Kaatje Bollaerts; Paolo Bonanni; Margaret Stanley; Rosybel Drury; Elmar Joura; Susanne K Kjaer; Chris J L M Meijer; Didier Riethmuller; Benoit Soubeyrand; Pierre Van Damme; Xavier Bosch
Journal:  Hum Vaccin Immunother       Date:  2018-05-24       Impact factor: 3.452

Review 9.  A comparative analysis of cervical cancer prevention between Nigeria and Nordic countries that have experienced a decline in cervical cancer incidence.

Authors:  Helen I Anyasi; Anna M Foss
Journal:  Int Health       Date:  2021-07-03       Impact factor: 2.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.